Search filters

List of works by Michelle R. Mahoney

A North Central Cancer Treatment Group Phase II trial of 9-aminocamptothecin in previously untreated patients with measurable metastatic colorectal carcinoma

scientific article

A Phase II study of high-dose paclitaxel in patients with advanced neuroendocrine tumors

scientific article published on 01 April 2001

A phase 2 consortium (P2C) trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) for advanced adenocarcinoma of the pancreas

scientific article

A phase 2 study of temsirolimus (CCI-779) in patients with soft tissue sarcomas: a study of the Mayo phase 2 consortium (P2C).

scientific article published in February 2011

Adverse Event Burden Score-A Versatile Summary Measure for Cancer Clinical Trials

scientific article published on 04 November 2020

Adverse-event rates: journals versus databases.

scientific article published in January 2007

Alliance A091103 a phase II study of the angiopoietin 1 and 2 peptibody trebananib for the treatment of angiosarcoma

scientific article

Alternating systemic and hepatic artery infusion therapy for resected liver metastases from colorectal cancer: a North Central Cancer Treatment Group (NCCTG)/ National Surgical Adjuvant Breast and Bowel Project (NSABP) phase II intergroup trial, N99

scientific article

An international, multicenter phase II trial of bortezomib in patients with hepatocellular carcinoma.

scientific article

Analysis of Molecular Markers by Anatomic Tumor Site in Stage III Colon Carcinomas from Adjuvant Chemotherapy Trial NCCTG N0147 (Alliance)

scientific article

CPT-11 for bile-duct and gallbladder carcinoma: a phase II North Central Cancer Treatment Group (NCCTG) study

scientific article

Challenges of conducting a prospective clinical trial for older patients: Lessons learned from NCCTG N0949 (alliance).

scientific article published on 13 September 2017

Chemotherapy, Irradiation, and Surgery for Function-preserving Curative Therapy of Primary Extremity Soft Tissue Sarcomas: Initial Treatment With I-MAP and Inhalation GM-CSF During Preoperative Irradiation and Postoperatively

scientific article

Chemotherapy, irradiation, and surgery for function-preserving therapy of primary extremity soft tissue sarcomas: initial treatment with ifosfamide, mitomycin, doxorubicin, and cisplatin plus granulocyte macrophage-colony-stimulating factor

scientific article

Clinicopathologic study of 85 similarly treated patients with anaplastic astrocytic tumors. An analysis of DNA content (ploidy), cellular proliferation, and p53 expression.

scientific article published in August 1999

Comparison of FOLFIRI with or without cetuximab in patients with resected stage III colon cancer; NCCTG (Alliance) intergroup trial N0147.

scientific article

Composite grading algorithm for the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

scientific article published on 01 December 2020

Contrast of response to dacarbazine, mitomycin, doxorubicin, and cisplatin (DMAP) plus GM-CSF between patients with advanced malignant gastrointestinal stromal tumors and patients with other advanced leiomyosarcomas

scientific article

Current use and surgical efficacy of laparoscopic colectomy in colon cancer

scientific article published on 24 April 2013

Dealing with a deluge of data: an assessment of adverse event data on North Central Cancer Treatment Group trials

scientific article

Early detection of toxicity and adjustment of ongoing clinical trials: the history and performance of the North Central Cancer Treatment Group's real-time toxicity monitoring program

scientific article

Effect of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Cetuximab on Survival Among Patients With Resected Stage III Colon Cancer ⬇️

scientific article published on April 4, 2012

Efficacy and quality-of-life data are related in a phase II trial of oral chemotherapy in previously untreated patients with metastatic colorectal carcinoma

scientific article

Evaluation of epothilone B analog in advanced soft tissue sarcoma: a phase II study of the phase II consortium.

scientific article

Gemcitabine, 5-fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma: a North Central Cancer Treatment Group phase II trial

scientific article

Hepatic Arterial Infusion and Systemic Chemotherapy After Multiple Metastasectomy in Patients With Colorectal Carcinoma Metastatic to the Liver: A North Central Cancer Treatment Group (NCCTG) Phase II Study, 92-46-52 ⬇️

scientific article published on May 13, 2011

Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients with locally advanced colon cancer

scientific article published in April 2002

KRAS codon 12 and 13 mutations in relation to disease-free survival in BRAF-wild-type stage III colon cancers from an adjuvant chemotherapy trial (N0147 alliance).

scientific article

Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes

scientific article

Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials

scientific article published on 19 January 2018

North Central Cancer Treatment Group N0543 (Alliance): A phase 2 trial of pharmacogenetic-based dosing of irinotecan, oxaliplatin, and capecitabine as first-line therapy for patients with advanced small bowel adenocarcinoma.

scientific article published on 10 May 2017

Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study

scientific article

Patient and tumor characteristics and BRAF and KRAS mutations in colon cancer, NCCTG/Alliance N0147

scientific article

Pemetrexed and oxaliplatin for metastatic colorectal cancer: results of a phase I Mayo Cancer Center Research Consortium trial, MC0248.

scientific article

Phase 2 study of bevacizumab plus erlotinib in patients with advanced hepatocellular cancer ⬇️

scientific article published on September 27, 2011

Phase I/II Randomized Trial of Sorafenib and Bevacizumab as First-Line Therapy in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma: North Central Cancer Treatment Group Trial N0745 (Alliance).

scientific article published on 9 December 2016

Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer

scientific article

Phase II study of MLN8237 (Alisertib) in advanced/metastatic sarcoma

scientific article published on 8 August 2016

Phase II study of daily oral perifosine in patients with advanced soft tissue sarcoma

scientific article published in November 2006

Phase II study of erlotinib in patients with advanced biliary cancer

scientific article

Phase II trial of gemcitabine in advanced sarcomas

scientific article

Phase III noninferiority trial comparing irinotecan with oxaliplatin, fluorouracil, and leucovorin in patients with advanced colorectal carcinoma previously treated with fluorouracil: N9841.

scientific article

Prognostic impact of deficient DNA mismatch repair in patients with stage III colon cancer from a randomized trial of FOLFOX-based adjuvant chemotherapy

scientific article

Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study

scientific article published in May 2004

Randomized Phase II Trial of Sulindac, Atorvastatin, and Prebiotic Dietary Fiber for Colorectal Cancer Chemoprevention ⬇️

scientific article published on January 5, 2011

Randomized clinical trial of high-dose levamisole combined with 5-fluorouracil and leucovorin as surgical adjuvant therapy for high-risk colon cancer

scientific article published on 01 July 2006

Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer

scientific article published on 01 November 1998

Randomized phase II study of daily versus continuous-infusion schedules of topotecan in the treatment of extensive-stage small cell lung cancers

scientific article

Rapid reporting and review of an increased incidence of a known adverse event

scientific article published in June 2000

RasGRP1 is a potential biomarker to stratify anti-EGFR therapy response in colorectal cancer

scientific article published on 25 June 2019

Report of a multicenter phase II trial testing a combination of biweekly bevacizumab and daily erlotinib in patients with unresectable biliary cancer: a phase II Consortium study

scientific article

Sorafenib for Advanced and Refractory Desmoid Tumors

scientific article published on 20 December 2018

Topotecan in patients with advanced neuroendocrine tumors: a phase II study with significant hematologic toxicity

scientific article

Paulina is supported by:

About Paulina

Help